HSBC Holdings
PRTK

HSBC Holdings’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

HSBC Holdings’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-32,640
Closed -$170K – 2912
2020
Q2 		$170K Buy
32,640
+21,888
+204% +$97.2K ﹤0.01% 2410
2020
Q1 		$34K Hold
10,752
– – ﹤0.01% 2594
2019
Q4 		$43K Hold
10,752
– – ﹤0.01% 2977
2019
Q3 		$46K Hold
10,752
– – ﹤0.01% 3022
2019
Q2 		$43K Sell
10,752
-1,933
-15% -$9.19K ﹤0.01% 2660
2019
Q1 		$68K Buy
12,685
+1,122
+10% +$7.25K ﹤0.01% 2644
2018
Q4 		$59K Buy
+11,563
New +$87.8K ﹤0.01% 2579

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HSBC Holdings's PRTK Position: Q3 2020 in Review

HSBC Holdings sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2020, closing a stake of 32,640 shares — an estimated $170K sold.

HSBC Holdings first reported a position in PRTK in Q4 2018 and held it in 7 quarters. The position peaked at $170K in Q2 2020. 100 funds tracked by Wall St. Rank hold PRTK as of Q3 2020.

  • HSBC Holdings reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • HSBC Holdings sold 32,640 Paratek Pharmaceuticals, Inc. shares in Q3 2020, an estimated $170K.
  • HSBC Holdings first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2018 and held it in 7 quarters.
  • HSBC Holdings's Paratek Pharmaceuticals, Inc. position peaked at $170K in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2020.

Based on HSBC Holdings's 13F filing for Q3 2020, filed 12 Nov 2020.